Gonçalves Pedro, Martel Fátima
Innate Immunity Unit, Institut Pasteur, and the Institut National de la Santé et de la Recherche Médicale (INSERM) U668, Paris, France.
Department of Biochemistry, Faculty of Medicine, and Institute for Research and Innovation in Health Sciences, University of Porto, Porto, Portugal.
Porto Biomed J. 2016 Jul-Aug;1(3):83-91. doi: 10.1016/j.pbj.2016.04.004. Epub 2016 Jul 1.
Fermentation of the dietary fiber by intestinal microflora results in production of butyrate.Butyrate possesses anticarcinogenic effect at the colonic level.Three transporters (MCT1, SMCT1 and BCRP) regulate the intracellular concentration of BT in colonic epithelial cells.Changes in the expression of these transporters occur in colorectal cancer.
Colorectal cancer (CRC) is one of the most common solid tumors worldwide. Consumption of dietary fiber is associated with a low risk of developing CRC. The fermentation of the dietary fiber by intestinal microflora results in production of butyrate (BT). This short-chain fatty acid is an important metabolic substrate in normal colonic epithelial cells and has important homeostatic functions at the colonic level. Because the cellular effects of BT (e.g. inhibition of histone deacetylases) are dependent on its intracellular concentration, knowledge on the mechanisms involved in BT membrane transport and its regulation seems particularly relevant. In this review, we will present the carrier-mediated mechanisms involved in BT membrane transport at the colonic epithelial level and their regulation, with an emphasis on CRC. Several xenobiotics known to modulate the risk for developing CRC are able to interfere with BT transport at the intestinal level. Thus, interference with BT transport certainly contributes to the anticarcinogenic or procarcinogenic effect of these compounds and these compounds may interfere with the anticarcinogenic effect of BT. Finally, we suggest that differences in BT transport between normal colonocytes and tumoral cells contribute to the "BT paradox" (the apparent opposing effect of BT in CRC cells and normal colonocytes).
肠道微生物群对膳食纤维的发酵会产生丁酸盐。丁酸盐在结肠水平具有抗癌作用。三种转运体(单羧酸转运体1、钠依赖性单羧酸转运体1和乳腺癌耐药蛋白)调节结肠上皮细胞内丁酸盐的浓度。这些转运体的表达变化发生在结直肠癌中。
结直肠癌(CRC)是全球最常见的实体瘤之一。膳食纤维的摄入与患CRC的低风险相关。肠道微生物群对膳食纤维的发酵会产生丁酸盐(BT)。这种短链脂肪酸是正常结肠上皮细胞中的重要代谢底物,在结肠水平具有重要的稳态功能。由于BT的细胞效应(如抑制组蛋白脱乙酰酶)取决于其细胞内浓度,因此了解BT膜转运及其调节机制似乎尤为重要。在本综述中,我们将介绍结肠上皮水平上BT膜转运的载体介导机制及其调节,重点是CRC。已知几种可调节患CRC风险的外源性物质能够在肠道水平干扰BT转运。因此,干扰BT转运肯定有助于这些化合物的抗癌或促癌作用,并且这些化合物可能会干扰BT的抗癌作用。最后,我们认为正常结肠细胞和肿瘤细胞之间BT转运的差异导致了“BT悖论”(BT在CRC细胞和正常结肠细胞中明显相反的作用)。